<bill session="116" type="h" number="3223" updated="2022-11-01T07:02:34Z">
  <state datetime="2019-06-12">REFERRED</state>
  <status>
    <introduced datetime="2019-06-12"/>
  </status>
  <introduced datetime="2019-06-12"/>
  <titles>
    <title type="display">Pharmacy Benefit Manager Accountability Study Act of 2019</title>
    <title type="official" as="introduced">To require the Comptroller General of the United States to study the role pharmacy benefit managers play in the pharmaceutical supply chain and to provide Congress with appropriate policy recommendations, and for other purposes.</title>
    <title type="short" as="introduced">Pharmacy Benefit Manager Accountability Study Act of 2019</title>
  </titles>
  <sponsor bioguide_id="M001198"/>
  <cosponsors>
    <cosponsor bioguide_id="A000378" joined="2019-10-04"/>
    <cosponsor bioguide_id="C001103" joined="2019-06-12"/>
    <cosponsor bioguide_id="G000581" joined="2019-06-12"/>
    <cosponsor bioguide_id="W000800" joined="2019-06-12"/>
  </cosponsors>
  <actions>
    <action datetime="2019-06-12">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-06-12" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2019-06-13">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Competition and antitrust"/>
    <term name="Congressional oversight"/>
    <term name="Consumer affairs"/>
    <term name="Drug therapy"/>
    <term name="Government studies and investigations"/>
    <term name="Health care costs and insurance"/>
    <term name="Health care coverage and access"/>
    <term name="Inflation and prices"/>
    <term name="Prescription drugs"/>
    <term name="User charges and fees"/>
  </subjects>
  <amendments/>
  <summary date="2020-01-25T18:49:23Z" status="Introduced in House">Pharmacy Benefit Manager Accountability Study Act of 2019

This bill requires the Government Accountability Office to study the role of pharmacy benefit managers (PBMs) with respect to federally facilitated exchanges,&#160;including the role of PBMs in pharmaceutical supply chains, the competition among PBMs, and the use of rebates and fees by PBMs in such exchanges.</summary>
</bill>
